Search results for: 'research area stem cell stem gsk 3'
-
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).
-
A4135 Tofacitinib (CP-690550) Citrate2 CitationTarget: JAKSummary: Potent JAK inhibitor
-
A2614 Bortezomib (PS-341)24 CitationTarget: ProteasomeSummary: Proteasome Inhibitor
-
A4137 AZD1480Target: JAKSummary: JAK2 inhibitor,ATP-competitive and novel
-
A1912 LomeguatribTarget: O6-methylguanine-DNA-methyl-transferase (MGMT)Summary: MGMT inhibitor
-
A4089 Mocetinostat (MGCD0103, MG0103)2 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC inhibitor,isotype-selective and potent
-
A8616 A-674563Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSKSummary: Akt1/PKA/CDK2 inhibitor,potent and selective
-
A5161 ImiquimodTarget: Toll-like receptors (TLRs)Summary: TLR-7 agonist,immunomodulator with antiviral and antitumor activity
-
A3760 ReversineTarget: Aurora KinasesSummary: A3 adenosine receptor antagonist,ARK-1/-2/-3 inhibitor
-
B5864 Fruquintinib(HMPL-013)Target: VEGFRSummary: Potent and selective inhibitor of VEGFR 1, 2, 3